6
Oct
2026
Shanghai Jinhe Bio-Pharmaceutical Co., Ltd.
About Shanghai Jinhe Bio-Pharmaceutical Co., Ltd.
Categories
Meet us at
-
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026stand 4D83
-
Country/Region:China
-
On CPHI since:2016
Products from Shanghai Jinhe Bio-Pharmaceutical Co., Ltd. (10)
-
Product 10 DABIII
Annal production ability above 1000kgs -
Product 4'-Demethyl-epi-Podophyllotoxin CAS: 6559-91-7
could provide CITEs -
Product 7-troc-Paclitaxel, CAS:114915-17-2
Paclitaxel N-1, -
Product 7,10-di-Troc-Docetaxel
Docetaxel N-1, CAS: 114915-14-9 -
Product Cabazitaxel
inhouse standard -
Product Docetaxel
Docetaxel, sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer.[1] This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non small-cell lung cancer.[2] It may be used by itself or along with other chemother... -
Product Docetaxel side chain, CAS: 949023-16-9
quantity above 1000kgs -
Product Irinotecan HCl Trihydrate USP39
Annual production ability above 100kgs. -
Product Paclitaxel side chain CAS: 196404-55-4
ANNUAL production ability above 1000kgs -
Product Palonosetron HCl
inhouse standard